Outsourced Pharma White Papers

  1. GLP-1 Peptides Around The World 8/12/2026

    Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.

  2. Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration 7/7/2025

    Learn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.

  3. Onshoring Advantage: 7 Forces Reshaping Global Biologics Manufacturing 10/27/2025

    Policy, trade, and security pressures are fundamentally reshaping global biologics manufacturing. Forward-looking companies are onshoring critical programs to mitigate risks to supply chains, IP, and regulatory timelines.

  4. Challenges And Solutions In Lyophilization Development For ADCs 12/10/2025

    Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing.

  5. Early-Phase Injectable Formulation Development 4/6/2026

    Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics.

  6. USP <665> Becomes Official On May 1, 2026. Are You Ready? 2/24/2026

    With USP <665> becoming official on May 1, 2026, proactive preparation is essential to ensure compliance and prevent delays, regulatory observations, or supply chain disruptions.

  7. Digital Innovation And Sustainability Are Redefining Biomanufacturing 12/8/2025

    Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production.

  8. Optimizing Safety Measures For rAAV Therapies 10/11/2024

    Explore common process-related impurities found in recombinant Adeno-Associated Virus (rAAV) vectors and the analytical testing methods used for these residuals.

  9. Modernizing Clinical Trial Logistics To Deliver Value 2/3/2026

    Explore how biopharma organizations can design and operate clinical supply systems that absorb complexity while maintaining control and consistency.

  10. Deciphering Nanoparticle Properties With AF4 5/6/2026

    Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.